Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label …
M Taboada, N Rodríguez, PM Varela… - European …, 2022 - Eur Respiratory Soc
Background Low-dose dexamethasone demonstrated clinical improvement in patients with
coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the …
coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the …
[HTML][HTML] Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label …
M Taboada, N Rodríguez, PM Varela… - The European …, 2022 - ncbi.nlm.nih.gov
Background Low-dose dexamethasone demonstrated clinical improvement in patients with
coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the …
coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the …
[PDF][PDF] Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label …
M Taboada, N Rodríguez, PM Varela, MT Rodríguez… - Eur Respir J, 2022 - academia.edu
Background Low-dose dexamethasone demonstrated clinical improvement in patients with
coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the …
coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the …
[HTML][HTML] Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 Pneumonia: an open-label …
M Taboada, N Rodríguez, PM Varela… - European …, 2021 - Eur Respiratory Soc
Background Low dose dexamethasone demonstrated clinical improvement in patients with
coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the …
coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the …
Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label …
M Taboada, N Rodríguez, PM Varela, MT Rodríguez… - 2022 - cabidigitallibrary.org
Background: Low-dose dexamethasone demonstrated clinical improvement in patients with
coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the …
coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the …
Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label …
M Taboada, N Rodríguez, PM Varela… - The European …, 2022 - europepmc.org
Background Low-dose dexamethasone demonstrated clinical improvement in patients with
coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the …
coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the …
[PDF][PDF] Early View
M Taboada, N Rodríguez, PM Varela, MT Rodríguez… - 2021 - scienceopen.com
Accepted manuscript form.indd Page 1 Early View Original research article Effect of high versus
low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or …
low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or …
[PDF][PDF] Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label …
M Taboada, N Rodríguez, PM Varela, MT Rodríguez… - Eur Respir J, 2022 - qdcxjkg.com
Background Low-dose dexamethasone demonstrated clinical improvement in patients with
coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the …
coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the …
Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label …
M Taboada, N Rodríguez, PM Varela, MT Rodríguez… - 2022 - pubmed.ncbi.nlm.nih.gov
Background Low-dose dexamethasone demonstrated clinical improvement in patients with
coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the …
coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the …
Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label …
M Taboada, N Rodríguez, PM Varela, MT Rodríguez… - 2022 - pubmed.ncbi.nlm.nih.gov
Background Low-dose dexamethasone demonstrated clinical improvement in patients with
coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the …
coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the …